Recurrent PE · participants with unprovoked acute symptomatic PE and at high risk for recurrent PEa
Retrievable vena caval filters with anticoagulation showed no clear difference in PE: recurrent fatal and non‐fatal PE, demonstrated by CT, pulmonary… compared with anticoagulation (moderate certainty).
1 finding from 1 review
Recurrent PE · participants who sustained multiple traumatic injuriesa
1 finding from 1 review
Number of days on antibiotics for acute exacerbations · adults and children with cystic fibrosis
Summary of findings: β‐carotene showed no clear difference in pulmonary exacerbations Days of antibiotic use compared with placebo (low certainty).
1 finding from 1 review
Pulmonary exacerbations · children (12 or over) and adults with cystic fibrosis and lung infection
Summary of findings: monoclonal antibody KB001‐A showed no clear difference in pulmonary exacerbations compared with placebo (low certainty).
1 finding from 1 review
Pulmonary exacerbations · children (12 or over) and young adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations number of participants requiring IV antibiotics · children with cystic fibrosis
Summary of findings: Zinc supplementation showed no clear difference in pulmonary exacerbations number of participants requiring IV… compared with placebo (moderate certainty).
1 finding from 1 review
Need for antibiotics see pulmonary exacerbations · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Bronchopulmonary dysplasia · preterm infants < 37 weeks' gestational age requiring conventional mechanical ventilation for respiratory distress syndrome
Oxygen‐guided lung‐recruitment maneuver showed no clear difference in bronchopulmonary dysplasia compared with routine care (low certainty).
1 finding from 1 review
Pulmonary complications (0 to 30 days) · Patients with lung cancer
NIPPV showed no clear difference in pulmonary complications compared with no NIPPV (low certainty).
1 finding from 1 review
Stone expulsion time · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Stone expulsion time · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Intervention not reported
Impulsivity Q‐sort, Porteus Maze Test (endpoints fall between 2 weeks and 6 months) · Any individual experiencing recurrent aggressive outbursts or episodes
1 finding from 1 review
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
Proportion of participants with adverse event1 Pain as assessed by VAS (0 to 10; higher score is worse) · Participants with rosacea
1 finding from 1 review
Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Assessment of erythema or telangiectasia1 Spectrophotometer to assess facial redness · Participants with rosacea
1 finding from 1 review
Lesion count ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Time needed until improvement ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review